Literature DB >> 15650358

Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.

Laurence Leenhardt1, Pascale Grosclaude, Laurence Chérié-Challine.   

Abstract

Thyroid cancer (TC) incidence, in France, has dramatically increased over the last two decades. In order to try and account for this observation, the French Department of Health requested the Public Health Agency to coordinate a multidisciplinary Thyroid Cancer Committee (TCC). The TCC analysed the temporal incidence trend in France, evaluated the contribution of changes in diagnostic practices of thyroid diseases to the observed increase of TC, and set up guidelines to improve the national surveillance system of TC. The increased incidence of TC is real (8.1% and 6.2% per year in women and in men, respectively), mainly due to papillary type with an epidemic of microcarcinomas (43% of operated cancers, period 1998-2001) associated to the extensiveness of thyroidectomies. Multicentric studies showed a significant increase, from 1980 to 2000, in ultrasonographic (3 to 84.8%) and cytological procedures (8 to 36% of patients with thyroid nodules) as well as a significant association between the increase in TC prevalence among operated patients (12.5 to 37%) and the spread of fine needle aspiration. Epidemiological evidence does not favour any link with the Chernobyl accident. The TCC recommended a national registry dedicated to thyroid cancer of the youths ( <18 years old). For adults, in addition with the strengthening of the French regional registries, a continuous registration of incident cases through the National Hospital Discharge Survey that covers all the territories is proposed. Such system, matched with pathological data derived from a national standardized collection, will provide a relevant model for epidemiological surveys of TC.

Entities:  

Mesh:

Year:  2004        PMID: 15650358     DOI: 10.1089/thy.2004.14.1056

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  113 in total

1.  The relationship between glucose metabolism disorders and malignant thyroid disease.

Authors:  Ayse Ocak Duran; Cüneyd Anil; Alptekin Gursoy; Aslı Nar; Ozden Altundag; Neslihan Bascil Tutuncu
Journal:  Int J Clin Oncol       Date:  2012-06-30       Impact factor: 3.402

2.  The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.

Authors:  Young Joo Park; Hwa Young Ahn; Hoon Sung Choi; Kyung Won Kim; Do Joon Park; Bo Youn Cho
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

3.  Usefulness of repeated recombinant human thyrotropin-stimulated thyroglobulin test in the post-surgical follow-up of very low-risk patients with differentiated thyroid carcinoma.

Authors:  C Cappelli; M Rotondi; I Pirola; E De Martino; E Gandossi; B Agosti; E Agabiti Rosei; L Chiovato; M Castellano
Journal:  J Endocrinol Invest       Date:  2011-11-07       Impact factor: 4.256

4.  Explaining the increasing incidence of differentiated thyroid cancer.

Authors:  Jacques How; Roger Tabah
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

5.  Role of GST and NAT2 polymorphisms in thyroid cancer.

Authors:  A Hernández; N Xamena; J Surrallés; P Galofré; A Velázquez; A Creus; R Marcos
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

6.  Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.

Authors:  Peng Hou; Ermal Bojdani; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2009-12-11       Impact factor: 5.958

Review 7.  Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.

Authors:  Tania Pilli; Kanteti V Prasad; Shankar Jayarama; Furio Pacini; Bellur S Prabhakar
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

8.  Thyroid cancer detected by mass screening over a period of 16 years at a health care center in Japan.

Authors:  Fumie Suehiro
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

9.  Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.

Authors:  Bo Youn Cho; Hoon Sung Choi; Young Joo Park; Jung Ah Lim; Hwa Young Ahn; Eun Kyung Lee; Kyung Won Kim; Ka Hee Yi; June-Key Chung; Yeo-Kyu Youn; Nam Han Cho; Do Joon Park; Chang-Soon Koh
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

10.  Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.

Authors:  Celestino P Lombardi; Rocco Bellantone; Carmela De Crea; Nunzia C Paladino; Guido Fadda; Massimo Salvatori; Marco Raffaelli
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.